CDER expert highlights advances in rare disease drug development
Feb 28 - Drug approvals, ARC Program offer support for patients with rare diseases
Feb 28 - Drug approvals, ARC Program offer support for patients with rare diseases
Feb 24 - Webinar will highlight major changes from the 2001 guidance
Feb 2 - Agency’s focus is on expanding the availability of and access to naloxone
Jan 31 - Details research activities around generic drug development
Jan 12 - Experts discuss BsUFA III goals and biosimilar regulatory science program
Jan 11 - First short-acting inhaler to contain a corticosteroid
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.